Funabashi, Japan

Yusuke Inaba



Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yusuke Inaba: Innovator in Calcium Channel Inhibition

Introduction

Yusuke Inaba is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target calcium channels. His work is particularly relevant for the treatment of pain, showcasing the intersection of innovation and healthcare.

Latest Patents

Yusuke Inaba holds a patent for a novel triazinone compound, which is recognized for its excellent T-type voltage-dependent calcium channel inhibitory activity. This compound is specifically useful for the treatment of pain. The patent details a compound of Formula (I), which includes various substituents defined in the claims, such as Ris H or Calkoxy. The compound's structure is designed to enhance its efficacy in medical applications.

Career Highlights

Inaba is associated with Nissan Chemical Industries Limited, where he applies his expertise in chemistry to develop innovative solutions. His work at the company has positioned him as a key player in the field of pharmaceutical development. With a focus on creating effective treatments, he continues to contribute to advancements in medical science.

Collaborations

Yusuke Inaba has collaborated with notable colleagues, including Noriko Saito and Jun Egi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yusuke Inaba's contributions to the field of medicinal chemistry, particularly through his patent on a triazinone compound, highlight his role as an innovator in pain treatment. His work at Nissan Chemical Industries Limited and collaborations with esteemed colleagues further emphasize his impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…